Investment firm Jefferies maintains its Buy rating on Vestis Corp, highlighting its well-executed turnaround strategy and potential for margin improvement ...
Deutsche Bank downgrades Masonite International's stock rating and increases price target, citing promising benefits from the recent agreement with Owens ...
Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...